Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Atrial fibrillation patients often receive needless treatment

Results of the Euro Heart Survey on atrial fibrillation (AF), demonstrate that many AF patients receive clot-preventing drugs while not at risk for stroke.

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Having three or more traits of the metabolic syndrome significantly increases the risk of dying from coronary heart disease, cardiovascular disease or any other cause, according to a study in Circulation: Journal of the American Heart Association.

25 Aug 2004

High blood pressure increased 30 percent over the last decade in the U.S.

The study found that at least 65 million Americans have hypertension, defined as blood pressure of 140/90 millimeters of mercury (mm Hg) or higher, using blood-pressure lowering medications, or having been told at least twice by a physician or other health professional that they had high blood pressure (medical history). By that definition, almost a third of U.S. adults have hypertension.

25 Aug 2004

New class of compounds play a role in protecting the cardiovascular system

Half a million Americans are diagnosed each year with heart failure, a progressively debilitating condition characterized by the heart's declining ability to pump blood efficiently.

25 Aug 2004

Striking increase in high blood pressure in the U.S.

A new analysis of the prevalence of high blood pressure in the US shows a striking increase over the last 10 years in the number of adults with this condition.

23 Aug 2004

Worldwide evidence says better care will halt heart failure epidemic

An international team of researchers from Australia, Canada, Italy and Scotland studying the results of heart failure management have found that managed care from specialist teams of health professionals can improve survival rates by up to 25 per cent.

23 Aug 2004

Nitroxyl-releasing drugs promise to revive failing hearts

Half a million Americans are diagnosed each year with heart failure, a progressively debilitating condition characterized by the heart's declining ability to pump blood efficiently.

22 Aug 2004

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.

21 Aug 2004

Revised cholesterol-lowering guidelines constitute a major risk to public health

Recently revised cholesterol-lowering guidelines constitute a major risk to public health according to The International Network of Cholesterol Skeptics, a non-profit organization of doctors, scientists and researchers.

18 Aug 2004

Researchers to conduct a series of studies on human circulation

Penn State College of Medicine researchers recently were awarded a five-year, $7 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to conduct a series of studies on human circulation.

18 Aug 2004

New guidelines urge early and long-term treatment with Aldosterone blockade therapy

Patients who have had a recent heart attack with ST-elevation (ST-Elevation Myocardial Infarction, or STEMI), complicated by heart failure should be treated with aldosterone blockers according to new guidelines issued recently by the American College of Cardiology (ACC) and the American Heart Association (AHA).

17 Aug 2004

Heart pump improves quality of life in congestive heart failure patients

The most seriously ill congestive heart failure patients live longer and have a better quality of life if implanted with a heart pump, researchers report in Circulation: Journal of the American Heart Association.

17 Aug 2004

A quarter of all adults aged over 40 could develop an irregular heartbeat

Atrial fibrillation is the most common heart rhythm disorder in the U.S., affecting more than 2 million adults. The prevalence of the condition is rising and scientists predict that about 5.6 million Americans will have the disorder by 2050. Known causes of AF include abnormalities in the heart’s structure and long-term uncontrolled high blood pressure.

17 Aug 2004

Important for physicians to identify patients at risk for hyperkalemia and implement corresponding measures when using ACE inhibitors

Some patients with hypertension or other cardiovascular diseases should be closely monitored in order to maintain safe potassium levels in the body when prescribed certain medications, counsels a nephrologist at UT Southwestern Medical Center at Dallas.

11 Aug 2004

Painless heart attacks often result in greater fatality rates than painful episodes

Painless heart attacks or heart conditions can be commonly overlooked and undertreated at the hospital, often resulting in greater fatality rates than painful episodes.

9 Aug 2004

Blood vessel plug - amplatzer ductal occluder, performs well in trial

In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT).

3 Aug 2004

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

Overwhelming evidence accumulated during almost 20 years of clinical experience has established the benefits of this drug, which blocks the harmful effects of angiotensin, a substance that causes blood vessels to narrow, said the study authors.

3 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Heart Failure News and Research

Further Reading

Atrial fibrillation patients often receive needless treatment

U.S. FDA study shows Canadian drugs to be more expensive

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

High blood pressure increased 30 percent over the last decade in the U.S.

New class of compounds play a role in protecting the cardiovascular system

Striking increase in high blood pressure in the U.S.

Worldwide evidence says better care will halt heart failure epidemic

Nitroxyl-releasing drugs promise to revive failing hearts

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

Revised cholesterol-lowering guidelines constitute a major risk to public health

Researchers to conduct a series of studies on human circulation

New guidelines urge early and long-term treatment with Aldosterone blockade therapy

Heart pump improves quality of life in congestive heart failure patients

A quarter of all adults aged over 40 could develop an irregular heartbeat

Important for physicians to identify patients at risk for hyperkalemia and implement corresponding measures when using ACE inhibitors

Painless heart attacks often result in greater fatality rates than painful episodes

Blood vessel plug - amplatzer ductal occluder, performs well in trial

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News